関連する実験動画

Updated: Sep 9, 2025

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

5.8K

ニボルマブによるメラノーマ治療中の遅発性血管免疫性T細胞リンパ腫

Akihiro Miyashita1,2, Taichi Murao3,2, Yuji Shimura2,4

  • 1Department of Internal Medicine, John A. Burns School of Medicine, University of Hawai'i, Honolulu, USA.

Cureus
|September 2, 2025
PubMed
まとめ

長期的な免疫チェックポイント阻害剤 (ICI) 治療は,がんに対して有効ですが,遅発のT細胞リンパ腫のリスクを増加させる可能性があります. 長期にわたるICI治療を受ける患者には,注意深いモニタリングが不可欠です.

キーワード:
血管免疫性T細胞リンパ腫コランジス免疫チェックポイント阻害剤免疫関連の有害事象ニボルマブ

さらに関連する動画

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues07:17

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

1.3K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.5K

関連する概念動画

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659